Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
Medidata Detect and Rave CTMS Have Improved Study Execution Through Role-Based Monitoring Workflows and Clinical Data Visualization for Hundreds of Customers Across More Than 9,000 Studies
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Subscribe To Our Newsletter & Stay Updated